Doctors from Vanderbilt University Medical Center, along with colleagues from First State Medical University. Pavlova showed that three different smoking cessation aids helped alcoholics reduce their alcohol consumption three months after starting treatment. The study was published in the journal JAMA Network Open.
Data for analysis were collected by doctors of the First State Medical University named after II. pavlova They selected 400 volunteers living with HIV in Russia to study. The study included participants who consumed five or more drinks per day (men) or four or more drinks per day (women) for five or more days in the past month and smoked five or more cigarettes per day.
They were divided into three groups depending on the drug the participants were taking: nicotine replacement therapy, varenicline, or cyticine. Participants were followed for 12 months after enrolling in the trials. The split was placebo-controlled, so neither the participants nor the researchers knew which drug was given to whom.
After three months, both alcohol and nicotine consumption decreased in all three groups. The researchers also showed that alcohol abstinence was higher among smokers.
People living with HIV are at greater risk for hepatitis, mental health problems, and multiple substance use. Such participants are often excluded from drug trials, and having a simple solution to recovery from addiction can greatly increase their chances of being included in studies. The study’s authors emphasize that excessive alcohol consumption and smoking often go hand in hand, both of which threaten health, increasing the risk of cardiovascular disease, cancer, and other diseases. Scientists believe more studies are needed to see if their results are directly related to medications, smoking cessation, or both.
The study was conducted by researchers from Vanderbilt University Medical Center (VUMC), Boston University School of Medicine, Boston Medical Center, Pavlov First State Medical University, Bekhterev National Center for Psychiatry and Neurology Medical Research, and the National Institutes of Health in Bethesda. Maryland.